Skip to main content
. Author manuscript; available in PMC: 2019 Mar 26.
Published in final edited form as: Prev Med. 2018 Dec 28;119:87–98. doi: 10.1016/j.ypmed.2018.12.024

Table 3.

Summary Statistics by CVH Strata

CVH Strata
All Favorable 1+ Elevated, None High 1 High 2 + High P-value
Sample Characteristics:
Avg. Age at Follow-up (years) 74.5 75.8 76.0 76.3 <0.001
Female, % 61.9 41.1 41.6 36.6 <0.001
White, % 88.2 91.5 90.6 90.7 0.194
Black, % 6.3 5.2 6.6 6.9 0.005
Avg. Age at CV Risk Measurement (years) 37.9 41.2 42.5 44.3 <0.001
With a High School Degree, % 34.6 34.6 38.5 39.9 <0.001
With a More than High School Degree, % 55.6 52.0 43.6 35.7 <0.001
 
Utilization and Costs:
Avg. No. of Acute Inpatient Admissions 0.19 0.24 0.29 0.38 <0.001
Avg. Acute Inpatient Length of Stay (days) 0.91 1.2 1.6 2.1 <0.001
Avg. No. of Post-acute inpatient admissions 0.04 0.04 0.05 0.07 <0.001
Avg. Post-acute inpatient Length of Stay (days) 0.97 1.3 1.5 1.9 <0.001
Avg. No. of Ambulatory Care Visits 14.6 15.4 15.8 17.1 <0.001
Avg. No. of Home Health Visits 1.4 2.0 2.5 3.8 <0.001
 
Total Costs, $ Median 1,548 1,819 1,854 2,241 <0.001
Mean 6,903 8,312 9,613 12,111 <0.001
  Acute Inpatient Costs, $ Median 0 0 0 0
Mean 2,601 3,378 4,202 5,742 <0.001
  Post-acute Inpatient Costs, $ Median 0 0 0 0
Mean 454 628 746 948 <0.001
  Ambulatory Care Costs, $ Median 1,464 1,679 1,665 1,906 <0.001
Mean 3,343 3,631 3,806 4,298 <0.001
  Home Health Care Costs, $ Median 0 0 0 0
Mean 317 405 498 723 <0.001
  Other Costs*, $ Median 0 0 0 0
Mean 187 270 361 401 <0.001
 
Sample Size (person-year) 8,226 34,945 64,980 50,155 <0.001
Number of CHA Participants 951 3,496 7,040 5,708 <0.001

Notes: Total sample size is 158,306 person-years. Costs are measured in 2016 dollars. P-values are obtained from Wald tests for the equality of the sample characteristics among the four risk strata.

*Other costs include costs for hospice care and durable medical equipment.